GlassScriptPhysician profile
Yvonne E Gilliland
NPI 1356309595
$12,682.51
in general payments reported to CMS, 2019-2025
18 companies · $9,601 in 2025
The $9,601 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $443 · 2021: $391 · 2022: $173 · 2023: $669 · 2024: $1,152 · 2025: $9,601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,560 · Food and Beverage: $3,996 · Consulting Fee: $2,865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,560.40 |
| Food and Beverage | $3,996.28 |
| Consulting Fee | $2,865.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,763.69 | 2025 | Pascal, Evoque |
| Abbott Laboratories | $3,732.64 | 2019-2025 | Navitor, Mitraclip, Triclip |
| E.R. Squibb & Sons, L.L.C. | $2,865.00 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $463.15 | 2023-2025 | Lifevest |
| Medtronic, INC. | $360.02 | 2023 | Corevalve Evolut R, Resolute Onyx |
| Janssen Pharmaceuticals, INC | $348.46 | 2020-2023 | Xarelto |
| Bard Peripheral Vascular, INC. | $222.40 | 2020-2022 | |
| Siemens Medical Solutions USA, INC. | $220.32 | 2020-2022 | |
| Inari Medical, INC. | $161.36 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Atricure, INC. | $160.93 | 2019-2025 | Synergy Ablation System |
| Abiomed | $148.82 | 2021 | |
| Livanova USA, INC. | $72.42 | 2023 | Tandemlife |
| Astrazeneca Pharmaceuticals LP | $48.50 | 2020-2023 | Andexxa |
| Pfizer INC. | $48.42 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $18.84 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $17.52 | 2021 | |
| Amgen INC. | $15.39 | 2021 | |
| Ge Healthcare | $14.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvonne Gilliland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.